Inventor · disambiguated record
Magnus Polla
Also filed as: POLLA MAGNUS
8 granted patents·12 pending applications·24 citations·filing 1998–2022
79Inventor score
Top patents by PatentIndex Score
20 records- 0172US7071175B1Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2000·Granted Jul 4, 2006·8 cites·23 claims
- 0258US2025042882A1Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0358US2025066338A1Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0457US2011130432A1Heterocyclic Carboxamides For Use As Thrombin InhibitorsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0557US2024417393A1Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0657US2025236627A1Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0756US2025115612A1Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4-b]pyrazines as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0855US6974800B1Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitorASTRAZENECA AB·Filed 2000·Granted Dec 13, 2005·3 cites·33 claims
- 0951US8119673B2Compounds 148BRAANALT JONAS·Filed 2009·Granted Feb 21, 2012·0 cites·4 claims
- 1051US6291475B1Bispidine antiarrhythmic compoundsASTRAZENECA AB·Filed 1998·Granted Sep 18, 2001·13 cites·30 claims
- 1150US7423012B2Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2005·Granted Sep 9, 2008·0 cites·14 claims
- 1244US7354895B1Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2000·Granted Apr 8, 2008·0 cites·14 claims
- 1341US7572817B22,5-disubstituted 3-mercaptopentanoic acidASTRAZENECA AB·Filed 2003·Granted Aug 11, 2009·0 cites·8 claims
- 1440US2004229900A1Bispidine compounds useful in the treatment of cardiac arrythmiasASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1540US2009012087A1New Aza-Bicyclohexane Compounds Useful As Inhibitors Of ThrombinASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1640US2008139607A1New CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1739US7375121B2Chemical compoundsASTRAZENECA AB·Filed 2002·Granted May 20, 2008·0 cites·5 claims
- 1839US2008039376A1Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates ThereofAZTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1936US2008207695A1Thrombin Inhibiting 2-Oxo-1,2,5,6-Tetrahydropyridine DerivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2036US2008214589A1Thrombin Inhibiting 2,4-Dioxo-3,4-Dihydropyrimidine DerivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Magnus Polla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →